Swanton Robert Charles

Swanton Robert Charles is listed in filings as Director at Bicycle Therapeutics plc. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to Bicycle Therapeutics plc (BCYC). The current snapshot covers public activity from Aug 14, 2025 to Jan 6, 2026. Reported amounts are shown as $52.8K to $186.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.